Findings

What do systematic reviews say?

5 questions · 5 findings · 3 reviews · Heart

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 40%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 20%Moderate 0 · 0%High 2 · 40%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Beta‐blockers vs placebo or no intervention · Serious adverse events at 'less than 3 months'
  Beta‐blockers for suspected or diagnosed acute myocardial infarction 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
Direct match · question page
- Exercise vs no exercise at the end of the intervention · Serious adverse events (
  Exercise‐based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator 2019 · Cochrane Headline outcomes only
  RR 1.05 [0.77, 1.44]
  2 studies · 356 participants
  Low
Direct match · question page
- Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) · Serious adverse events
  Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
  RR 0.47 [0.25, 0.9]
  1 study · 108 participants
  High
Direct match · question page
- Beta‐blockers vs placebo or no intervention · Serious adverse events at maximum
  Beta‐blockers for suspected or diagnosed acute myocardial infarction 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
Direct match · question page
- Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo · Serious adverse events
  Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
  RR 0.45 [0.28, 0.7]
  2 studies · 432 participants
  High

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs Western medicine

Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease

Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) (high certainty).

1 finding from 1 review

Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
RR 0.47 [0.25, 0.9]
1 study · 108 participants
High

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo

Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease

Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) plus placebo (high certainty).

1 finding from 1 review

Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
RR 0.45 [0.28, 0.7]
2 studies · 432 participants
High

Exercise vs no exercise

Serious adverse events ( · adult patients with an implantable cardioverter defibrillator

Exercise showed no clear difference in serious adverse events ( compared with no exercise at the end of the intervention (low certainty).

1 finding from 1 review

Exercise‐based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator 2019 · Cochrane Headline outcomes only
RR 1.05 [0.77, 1.44]
2 studies · 356 participants
Low

Beta‐blockers vs placebo or no intervention

Serious adverse events maximum · patients with suspected or diagnosed myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Beta‐blockers for suspected or diagnosed acute myocardial infarction 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Beta‐blockers vs placebo or no intervention

Serious adverse events at 'less than 3 months' · patients with suspected or diagnosed myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Beta‐blockers for suspected or diagnosed acute myocardial infarction 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found